Status:
UNKNOWN
Using Microfluidic Separation Sperm Selection for Unexplained Infertility and Reccurrent Implantation Failure
Lead Sponsor:
Acibadem University
Conditions:
Unexplained Infertility
Recurrent Implantation Failure
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
In order to increase the likelihood of achieving IVF-treated pregnancy, good quality embryo transfer is important. To get good quality embryos, good quality gametes are needed. The selection of sperm ...
Detailed Description
Patients will be treated with conventional IVF treatment. A vaginal ultrasound (US) examination will be perform on day 3 of the cycle for assessment of ovarian size and to exclude patients with large ...
Eligibility Criteria
Inclusion
- Unexplained Infertility Group; The inclusion criteria are;
- normal HSG,
- normal hormone levels,
- normal over functions,
- having normal uterine cavity and endometrial thickness determined by office hysteroscopy
- no endometriosis (determined by transvaginal ultrasonography and / or diagnostic laparoscopy)
- normal spermiogram result Recurrent Implantation Failure The inclusion criteria are;
- 1-The inclusion criteria of the working group are: 2-Failure of embryo transfer at least twice after high quality embryo transfer after 3-IVF treatment, 4-having normal hormone reserve (FSH \<8 mIU / mL), 5-respond well to hormone stimulation (\> 8 oocyte collection), 6-having normal uterine cavity and endometrial thickness determined by office hysteroscopy
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03355937
Start Date
January 1 2018
End Date
December 31 2019
Last Update
November 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acibadem Fulya Hospital
Istanbul, Besiktas, Turkey (Türkiye), 34349